![Christopher Bebbington](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Bebbington
No open positions remaining
Profile
Christopher Bebbington was the founder of Allakos, Inc. which was founded in 2012, where he held the title of President & Chief Executive Officer.
Dr. Bebbington is also the founder of Celscia Therapeutics, Inc. Dr. Bebbington's former jobs include Director-Molecular Immunology at Coulter Pharmaceuticals, Inc., Senior Research Director at Corixa Corp., Vice President-Research at Humanigen, Inc., and Head-Mammalian Expression Division at Celltech Ltd. Dr. Bebbington received his undergraduate, graduate, and doctorate degrees from the University of Oxford.
Former positions of Christopher Bebbington
| Companies | Position | End |
|---|---|---|
| ALLAKOS INC. | Chief Executive Officer | - |
| HUMANIGEN, INC. | Chief Tech/Sci/R&D Officer | - |
Celscia Therapeutics, Inc.
 Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases | Founder | - |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Chief Tech/Sci/R&D Officer | - |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Corporate Officer/Principal | - |
Training of Christopher Bebbington
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases | Commercial Services |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural science and engineering | Commercial Services |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
- Stock Market
- Insiders
- Christopher Bebbington
